4 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 17981038 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | SOROUSH, LAYLA | 1622 | Non-Final OA | Nov 04, 2022 |
| 17847577 | TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY | POPA, ILEANA | 1633 | Final Rejection | Jun 23, 2022 |
| 17341027 | PREVENTING OR MITIGATING CHEMOTHERAPY INDUCED ALOPECIA USING VITAMIN D | RODRIGUEZ, RAYNA B | 1628 | Final Rejection | Jun 07, 2021 |
| 17274405 | METHODS OF TREATING CANCER BY INHIBITING UBIQUITIN CONJUGATING ENZYME E2 K (UBE2K) | SULLIVAN, STEPHANIE LAUREN | 1635 | Non-Final OA | Mar 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial